Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Drebbin

RE: Drebbin

posted on Sep 19, 2006 10:43AM
``We reiterate that the decision by the Company to account for its interest in Phoenix Digital Solutions, LLC in accordance with the equity method of accounting for investments and its decision to bifurcate the embedded derivatives in its previously outstanding convertible debentures will not have a material effect on the Company`s financial condition.``

Respond, please.

Need to break this down to understand it. Need the brightest and the best. Bifurcate is ``to split`` ... so they previously had split out the embedded derivatives on the outstanding convertible debentures? Not sure what that means to a companies financial position.

Share
New Message
Please login to post a reply